Page 105 - 2021年19期
P. 105
tions in Italian adult patients[J]. Eur J Drug Metab Phar- mycin and teicoplanin-based stationary phases,a tool for
macokinet,2020,45(3):405-412. chiral recognition of model β-blockers[J]. J Chromatogr
[ 9 ] 曹伟,卢志品,余剑华.利奈唑胺是否需要血药浓度监 Sci,2019 ,57(6):485-494.
测?[J].中国新药与临床杂志,2016,35(10):690-694. [23] DEV A,JANYSEK D,GNECCO J,et al. Disseminated
[10] ALGHAMDI W A,AL-SHAER M H,KLINKER P K, coccidioidomycosis following insufficient treatment at ini-
et al. Variable linezolid exposure and response and the tial presentation:case report[J]. J Investig Med High Im-
role of therapeutic drug monitoring:case series[J]. Clin pact Case Rep,2020,8:23.
Case Rep,2020,8(7):1126-1129. [24] 刘朝霞,周亚楠,何兰,等.二维液相色谱技术在药物分析
[11] FANG J,CHEN C,WU Y,et al. Does the conventional 中的应用[J].中国药学杂志,2019,54(12):941-946.
dosage of linezolid necessitate therapeutic drug monito- [25] 国家药典委员会.中华人民共和国药典:四部[S].2020年
ring? Experience from a prospective observational study[J]. 版.北京:中国医药科技出版社,2020:363.
Ann Transl Med,2020,8(7):493. [26] RIZZELLO I,CASTAGNETTI F,TOSCHI P G,et al.
[12] 李红莲,张峻,卢珊珊.替考拉宁血药浓度监测的研究概 Successful treatment of bilateral endogenous fusarium so-
述[J].国际药学研究杂志,2019,46(7):492-497. lani endophthalmitis in a patient with acute lymphocytic
[13] 王敏.万古霉素血药浓度监测对临床用药指导意义的分 leukaemia[J]. Mycoses,2018,61(1):53-60.
析[J].临床医学研究与实践,2020,5(16):108-110. [27] NGUYEN K Q,HAWKINS M G,TAYLOR I T,et al. Sta-
[14] 周红,胡晓红,黄潇,等.新型冠状病毒肺炎疫情下治疗药 bility and uniformity of extemporaneous preparations of
物监测实验室感染防控策略[J].医药导报,2020,39(3): voriconazole in two liquid suspension vehicles at two sto-
330-333. rage temperatures[J]. Am J Vet Res,2009,70(7):908-914.
[15] 米元元,黄海燕,朱丽群,等.新型冠状病毒患者标本采集 [28] 雷银瓶,金波,李彤,等. UFLC-MS/MS 法研究利奈唑胺
技术专家共识[J].护士进修杂志,2020,35(12):1124- 片强制降解杂质[J].药学学报,2017,52(6):971-976.
1128. [29] VU D H,BOLHUIS M S,KOSTER R A,et al. Dried
[16] PENG X,XU X,LI Y,et al. Transmission routes of 2019- blood spot analysis for therapeutic drug monitoring of li-
nCoV and controls in dental practice[J]. Int J Oral Sci, nezolid in patients with multidrug-resistant tuberculo-
2020,12(1):9. sis[J]. Antimicrob Agents Chemother,2012,56(11):
[17] LI H,LIANG R,PANG Y,et al. Evidence for interspecies 5758-5763.
transmission route of pseudorabies virus via virally con- [30] VAUGHAN L M,POON C Y. Stability of ceftazidime and
taminated fomites[J]. Vet Microbiol,2020,251:108912. vancomycin alone and in combination in heparinized and
[18] BOUCHAND C,NGUYEN D,SECRETAN P H,et al. nonheparinized peritoneal dialysis solution[J]. Ann Phar-
Voriconazole topical cream formulation:evidence for sta- macother,1994,28(5):572-576.
bility and antifungal activity[J]. Int J Antimicrob Agents, [31] GALANTI L M,HECQ J D,JEUNIAU P,et al. Assess-
2020,56(3):106083. ment of the stability of teicoplanin in intravenous infu-
[19] 刘筱英,谷利凤.干热灭菌法在医疗无菌物品处理中的应 sions[J]. Int J Pharm Compd,2001,5(5):397-400.
用进展[J].当代护士(学术版),2008(6):9-11. [32] 赵博欣,刘思佳,刘媛,等.血液标本灭活处理对液相串联
[20] 崔立勋.湿热灭菌方法分析[J].黑龙江医药,2012,25(1): 质谱法伏立康唑治疗药物监测的影响及其在COVID-19
107-108. 疫情期间的应用[J].南方医科大学学报,2020,40(3):
[21] TENGATTINI S,CORANA F,BIANCHI D,et al. Appli- 342-345.
cation of an HPLC-MS/MS method for teicoplanin drug [33] 张晓旭,侯林中,姜晖,等.新型冠状病毒灭活方式对高效
substance and related impurities:part 2:identity assign- 液相色谱法监测万古霉素血药浓度的影响[J].中国药
ment of related impurities[J]. J Pharm Biomed Anal, 业,2020,29(9):27-29.
2019,168:38-43. (收稿日期:2021-03-02 修回日期:2021-08-14)
[22] GEORGE N,HERZ M,ABOUL-ENEIN H Y,et al. Sur- (编辑:林 静)
face design of enantiomeric HPLC separation on vanco-
中国药房 2021年第32卷第19期 China Pharmacy 2021 Vol. 32 No. 19 ·2399 ·